+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever



The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever



Lancet. Infectious Diseases 11(8): 622-632



The changing epidemiology of yellow fever and continued reports of rare but serious adverse events associated with yellow fever vaccine have drawn attention to the need to revisit criteria for the designation of areas with risk for yellow fever virus activity, and to revise the vaccine recommendations for international travel. WHO convened a working group of international experts to review factors important for the transmission of yellow fever virus and country-specific yellow fever information, to establish criteria for additions to or removal from the list of countries with risk for yellow fever virus transmission, to update yellow fever risk maps, and to revise the recommendations for vaccination for international travel. This report details the recommendations made by the working group about criteria for the designation of risk and specific changes to the classification of areas with risk for transmission of yellow fever virus.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056466724

Download citation: RISBibTeXText

PMID: 21798462

DOI: 10.1016/S1473-3099(11)70147-5


Related references

Travel characteristics and yellow fever vaccine usage among US Global TravEpiNet travelers visiting countries with risk of yellow fever virus transmission, 2009-2011. American Journal of Tropical Medicine and Hygiene 88(5): 954-961, 2013

Immunological studies with group B arthropod-borne viruses. IV. Persistence of yellow fever antibodies following vaccination with 17D strain yellow fever vaccine. American Journal of Tropical Medicine and Hygiene 12: 230-235, 1963

Immunological studies with Group B arthropod-borne viruses. IV. Persistence of yellow fever antibodies following vaccination with 17D strain yellow fever vaccine. Amer Jour Trop Med And Hyg 12(2): 230-235, 1962

Revised recommendations for yellow fever vaccination for international travellers, 2011. Releve Epidemiologique Hebdomadaire 86(37): 401-411, 2011

A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination. Plos One 11(3): E0149871, 2016

Isolation and characterization of wild type yellow fever virus in cases temporally associated with 17DD vaccination during an outbreak of yellow fever in Brazil. Vaccine 22(9-10): 1073-1078, 2004

Detection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination. American Journal of Tropical Medicine and Hygiene 87(6): 1112-1115, 2013

Yellow fever vaccination and risk of spontaneous abortion. Tropical Medicine & International Health 3(8): 687, 1998

Yellow fever recommendations for tourists to Kenya: a flawed risk assessment. Journal of Travel Medicine 16(2): 146; Author Reply 146-7, 2009

Yellow fever recommendations for tourists to Kenya: a flawed risk assessment?. Journal of Travel Medicine 15(5): 285-286, 2008

Advanced age a risk factor for illness temporally associated with yellow fever vaccination. Emerging Infectious Diseases 7(6): 945-951, 2001

Yellow fever vaccination, avian leukosis virus, and cancer risk in man. Science 177(4043): 76-77, 1972

Age-related risk of adverse events following yellow fever vaccination in Australia. Communicable Diseases Intelligence Quarterly Report 28(2): 244-248, 2004

Entomological assessment of yellow fever-epidemic risk indices in Benue State, Nigeria, 2010-2011. Acta Tropica 161: 18-25, 2016

Genetic relationships and evolution of genotypes of yellow fever virus and other members of the yellow fever virus group within the Flavivirus genus based on the 3' noncoding region. Journal of Virology 78(18): 9652-9665, 2004